# US 2019/0317109 A1 · Thyroglobulin quantitation by mass spectrometry

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0317109 A1
- Document ID: US20190317109A1
- Status: Published application
- Kind: A1
- Application number: 16/429,941
- Filed: 2019-06-03
- Published: 2019-10-17
- Earliest claimed: 2007-12-06
- Assignees: Quest Diagnostics Investments Incorporated
- Applicants: Quest Diagnostics Investments Incorporated
- Inventors: Yanni Zhang; Nigel J. Clarke; Richard E Reitz
- Web page: https://patentgrep.com/patent/US20190317109A1

## CPC

- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- G01N 33/6893: {related to diseases not provided for elsewhere}
- G01N 33/78: Thyroid gland hormones {, e.g. T3, T4, TBH, TBG or their receptors}
- G01N 2800/52: Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
- G01N 2800/7028: Cancer
- Y10T 436/24: Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- Y10T: TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION

## Abstract

Provided are methods for determining the amount of thyroglobulin in a sample using various purification steps followed by mass spectrometry. The methods generally involve purifying thyroglobulin in a test sample, digesting thyroglobulin to form peptide T129, purifying peptide T129, ionizing peptide T129, detecting the amount of peptide T129 ion generated, and relating the amount of peptide T129 ion to the amount of thyroglobulin originally present in the sample.

## Claims

### Claim 1

A method for determining the amount of thyroglobulin in a sample, comprising:
(a) digesting a serum or plasma sample containing thyroglobulin with trypsin to generate a thyroglobulin peptide;
(b) purifying the sample containing thyroglobulin peptide by liquid chromatography;
(c) ionizing the thyroglobulin peptide with electrospray ionization (ESI) to generate one or more ions detectable by mass spectrometry;
(d) quantifying the amount of the one or more thyroglobulin peptide ions from step (c) by mass spectrometry;
(e) relating the amount of the one or more thyroglobulin peptide ions to the amount of thyroglobulin in the serum or plasma sample.

### Claim 2 (depends on 1)

The method of claim 1, wherein the serum or plasma sample is taken from a patient suffering from thyroid cancer.

### Claim 3 (depends on 1)

The method of claim 1, wherein the mass spectrometry is tandem mass spectrometry.

### Claim 4 (depends on 1)

The method of claim 1, wherein the mass spectrometry is performed in positive ion mode.

### Claim 5 (depends on 1)

The method of claim 1, wherein the mass spectrometry is quadrupole or time-of-flight (TOF) mass spectrometry.

### Claim 6 (depends on 5)

The method of claim 5, wherein the TOF mass spectrometry is matrix-assisted laser desorption ionization coupled with TOF (MALDI-TOF).

### Claim 7 (depends on 1)

The method of claim 1, wherein the liquid chromatography is high performance liquid chromatography (HPLC).

### Claim 8 (depends on 1)

The method of claim 1, further comprising using a C18 column.
